Surgical management of hepato-pancreatic metastasis from renal cell carcinoma

Table 2 Individual case characteristics

Patient	Age, gender	Site of metastasis	Time nephrectomy to metastasis (mo)	Other metastasis pre-operatively	Operation	Post-operative complications	Follow-up (mo)	Status at last follow-up	Site of recurrence	Time from resection of metastasis to recurrence (mo)
1	50, female	Pancreas	73	Lungs (resected)	PD	Bleeding, pancreatic fistula	50	Alive, disease-free	-	-
2	61, female	Pancreas	110	-	PD	Collection	66	Alive, recurrence	Right iliac bone (radiation)	28
3	64, male	Pancreas	93	-	TP + S	-	98	Alive, recurrence	Pancreatic bed recurrence and abdominal LN (Pazopanib)	53
4	66, male	Pancreas	292	-	TP	-	4	Death from disease	Brain (radiation)	3
5	63, male	Pancreas	0	-	Laparoscopic DP + S	-	61	Alive, disease-free	Liver	17
		Liver	28		Laparoscopic non-anatomical				-	-
6	63, female	Pancreas	10	-	DP + S	Pancreatic fistula	16	Alive, recurrence	Right kidney and lung (Pazopanib)	5
7	80, female	Pancreas	26	-	PD	Bleeding, collection	3	Death, no evidence of disease	-	-
8	65, male	Liver	29	-	Non-anatomical	-	94	Death, no evidence of disease	Lungs (resected)	55
9	44, female	Liver	0	-	Non-anatomical	Chylous scites	23	Death, recurrence	Liver (Pazopanib)	6
10	70, male	Liver	4	Right kidney	Non-anatomical + right partial nephrectomy	-	33	Death, recurrence	Lung and spine (radiation and Sunitinib)	3
11	61, female	Liver	0	Right adrenal, lungs (resected)	Non-anatomical	-	36	Alive, disease-free	-	-
12	59, male	Liver	40	Adrenal (in specimen of RCC resection) Lungs	Non-anatomical + diaphragm	-	32	Alive, recurrence	Liver (Pazopanib)	10
13	65, male	Liver	129	Lungs	Right hepatectomy + IVC resection	-	26	Alive, with disease, no recurrence	-	-

RCC: Renal cell carcinoma; IVC: Inferior vena cava; PD: Pancreaticoduodenectomy; TP + S: Total pancreatectomy and splenectomy; DP + S: Distal pancreatectomy and splenectomy; LN: Lymph nodes.